BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 17722310)

  • 1. Treatment of idiopathic menorrhagia with tranexamic acid.
    Srinil S; Jaisamrarn U
    J Med Assoc Thai; 2005 Oct; 88 Suppl 2():S1-6. PubMed ID: 17722310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A multicenter prospective randomized open comparative study on the treatment of ovulatory menorrhagia with tranexamic acid and norethisterone in China].
    Zhang YW; He FF; Sun ZY; Li SW; Bi SL; Huang XL; Cao ZS; Lü SL; Lu JL; Zhang ZY; Zhu YM; Huang HF; Miao MH
    Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):247-50. PubMed ID: 18843961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multisite management study of menorrhagia with abnormal laboratory haemostasis: a prospective crossover study of intranasal desmopressin and oral tranexamic acid.
    Kouides PA; Byams VR; Philipp CS; Stein SF; Heit JA; Lukes AS; Skerrette NI; Dowling NF; Evatt BL; Miller CH; Owens S; Kulkarni R
    Br J Haematol; 2009 Apr; 145(2):212-20. PubMed ID: 19236375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts.
    Reid PC; Virtanen-Kari S
    BJOG; 2005 Aug; 112(8):1121-5. PubMed ID: 16045528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uterine artery blood flow parameters in women with dysfunctional uterine bleeding and uterine fibroids: the effects of tranexamic acid.
    Lakhani KP; Marsh MS; Purcell W; Hardiman P
    Ultrasound Obstet Gynecol; 1998 Apr; 11(4):283-5. PubMed ID: 9618854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of tranexamic acid in management of dysfunctional uterine bleeding in comparison with medroxyprogesterone acetate.
    Kriplani A; Kulshrestha V; Agarwal N; Diwakar S
    J Obstet Gynaecol; 2006 Oct; 26(7):673-8. PubMed ID: 17071438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifibrinolytics in women with menorrhagia.
    Philipp CS
    Thromb Res; 2011 Feb; 127 Suppl 3():S113-5. PubMed ID: 21262428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of tranexamic acid and norethisterone in the treatment of ovulatory menorrhagia.
    Preston JT; Cameron IT; Adams EJ; Smith SK
    Br J Obstet Gynaecol; 1995 May; 102(5):401-6. PubMed ID: 7612535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral modified-release tranexamic acid for heavy menstrual bleeding.
    Hrometz SL
    Ann Pharmacother; 2012; 46(7-8):1047-53. PubMed ID: 22811348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of heavy menstrual bleeding of endometrial origin: randomized controlled trial of medroxyprogesterone acetate and tranexamic acid.
    Goshtasebi A; Moukhah S; Gandevani SB
    Arch Gynecol Obstet; 2013 Nov; 288(5):1055-60. PubMed ID: 23595582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tranexamic acid: a review of its use in the management of menorrhagia.
    Wellington K; Wagstaff AJ
    Drugs; 2003; 63(13):1417-33. PubMed ID: 12825966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating a meaningful reduction in menstrual blood loss for women with heavy menstrual bleeding.
    Lukes AS; Muse K; Richter HE; Moore KA; Patrick DL
    Curr Med Res Opin; 2010 Nov; 26(11):2673-8. PubMed ID: 20942615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic studies in women of 2 novel oral formulations of tranexamic acid therapy for heavy menstrual bleeding.
    Moore KA; Morin I; Marenco T; Lavigne JR; Morelli G
    Am J Ther; 2012 May; 19(3):190-8. PubMed ID: 21248612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral micronised flavonoids versus tranexamic acid for treatment of heavy menstrual bleeding secondary to copper IUD use: a randomised double-blind clinical trial.
    Alanwar A; Abbas AM; Hussain SH; Elhawwary G; Mansour DY; Faisal MM; Elshabrawy A; Eltaieb E
    Eur J Contracept Reprod Health Care; 2018 Oct; 23(5):365-370. PubMed ID: 30247074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid.
    Bonnar J; Sheppard BL
    BMJ; 1996 Sep; 313(7057):579-82. PubMed ID: 8806245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment by tranexamic acid in menorrhagia in women using intrauterine devices].
    Bengtsson LP; Weström L
    Lakartidningen; 1971 Aug; 68(33):3685-91. PubMed ID: 5129410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Women and von Willebrand disease: controversies in diagnosis and management.
    Kadir RA; Chi C
    Semin Thromb Hemost; 2006 Sep; 32(6):605-15. PubMed ID: 16977570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thorough cardiac QTc interval conductance assessment of a novel oral tranexamic acid treatment for heavy menstrual bleeding.
    Moore KA; Callahan TS; Maison-Blanche P; Morin I; Marenco T; Swearingen D; Olbertz J
    Expert Opin Pharmacother; 2010 Oct; 11(14):2281-90. PubMed ID: 20698724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dose-response study of a novel, oral tranexamic formulation for heavy menstrual bleeding.
    Freeman EW; Lukes A; VanDrie D; Mabey RG; Gersten J; Adomako TL
    Am J Obstet Gynecol; 2011 Oct; 205(4):319.e1-7. PubMed ID: 21777897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tranexamic acid therapy for heavy menstrual bleeding.
    Lumsden MA; Wedisinghe L
    Expert Opin Pharmacother; 2011 Sep; 12(13):2089-95. PubMed ID: 21767224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.